145 related articles for article (PubMed ID: 19502819)
1. Inhibition of Aurora-A results in increased cell death in 3-dimensional culture microenvironment, reduced migration and is associated with enhanced radiosensitivity in human nasopharyngeal carcinoma.
Wan XB; Fan XJ; Chen MY; Xu J; Long ZJ; Hua YJ; Ji H; Liu L; Hong MH; Zeng YX; Liu Q
Cancer Biol Ther; 2009 Aug; 8(15):1500-6. PubMed ID: 19502819
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells.
Wan XB; Long ZJ; Yan M; Xu J; Xia LP; Liu L; Zhao Y; Huang XF; Wang XR; Zhu XF; Hong MH; Liu Q
Carcinogenesis; 2008 Oct; 29(10):1930-7. PubMed ID: 18667445
[TBL] [Abstract][Full Text] [Related]
3. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma.
Liu T; Sun Q; Li Q; Yang H; Zhang Y; Wang R; Lin X; Xiao D; Yuan Y; Chen L; Wang W
Mol Cancer Ther; 2015 Feb; 14(2):429-39. PubMed ID: 25504751
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells.
Xu DR; Huang S; Long ZJ; Chen JJ; Zou ZZ; Li J; Lin DJ; Liu Q
J Transl Med; 2011 May; 9():74. PubMed ID: 21600017
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells.
Guan Z; Wang XR; Zhu XF; Huang XF; Xu J; Wang LH; Wan XB; Long ZJ; Liu JN; Feng GK; Huang W; Zeng YX; Chen FJ; Liu Q
Cancer Res; 2007 Nov; 67(21):10436-44. PubMed ID: 17974987
[TBL] [Abstract][Full Text] [Related]
6. Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.
Huang XF; Luo SK; Xu J; Li J; Xu DR; Wang LH; Yan M; Wang XR; Wan XB; Zheng FM; Zeng YX; Liu Q
Blood; 2008 Mar; 111(5):2854-65. PubMed ID: 18160664
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells.
Pan C; Yan M; Yao J; Xu J; Long Z; Huang H; Liu Q
Oral Oncol; 2008 Jul; 44(7):639-45. PubMed ID: 17996488
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma.
Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B
Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838
[TBL] [Abstract][Full Text] [Related]
9. The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.
Pezzani R; Rubin B; Bertazza L; Redaelli M; Barollo S; Monticelli H; Baldini E; Mian C; Mucignat C; Scaroni C; Mantero F; Ulisse S; Iacobone M; Boscaro M
Invest New Drugs; 2016 Oct; 34(5):531-40. PubMed ID: 27177645
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
[TBL] [Abstract][Full Text] [Related]
11. Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.
Luo S; Huang G; Wang Z; Wan Z; Chen H; Liao D; Chen C; Li H; Li B; Chen L; Huang Z; He Z
Int J Clin Exp Pathol; 2015; 8(9):9990-10001. PubMed ID: 26617707
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy.
Kou J; Wang X; Wei Y; Zhao R; Wang X; He J; Li X; Wang X
Anticancer Drugs; 2021 Oct; 32(9):969-977. PubMed ID: 34016831
[TBL] [Abstract][Full Text] [Related]
13. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo.
Nguyen TH; Ong CK; Wong E; Leong CT; Panasci L; Huynh H
Int J Oncol; 2005 Oct; 27(4):1131-40. PubMed ID: 16142332
[TBL] [Abstract][Full Text] [Related]
14. A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines.
Chowdhury A; Chowdhury S; Tsai MY
Leuk Lymphoma; 2012 Mar; 53(3):462-71. PubMed ID: 21879811
[TBL] [Abstract][Full Text] [Related]
15. Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53.
Cheok CF; Kua N; Kaldis P; Lane DP
Cell Death Differ; 2010 Sep; 17(9):1486-500. PubMed ID: 20203688
[TBL] [Abstract][Full Text] [Related]
16. Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia.
Donato NJ; Fang D; Sun H; Giannola D; Peterson LF; Talpaz M
Biochem Pharmacol; 2010 Mar; 79(5):688-97. PubMed ID: 19874801
[TBL] [Abstract][Full Text] [Related]
17. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z
Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1.
Tan Y; Wei X; Zhang W; Wang X; Wang K; Du B; Xiao J
Oncol Rep; 2017 Mar; 37(3):1833-1841. PubMed ID: 28184930
[TBL] [Abstract][Full Text] [Related]
20. Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines.
Arlot-Bonnemains Y; Baldini E; Martin B; Delcros JG; Toller M; Curcio F; Ambesi-Impiombato FS; D'Armiento M; Ulisse S
Endocr Relat Cancer; 2008 Jun; 15(2):559-68. PubMed ID: 18430894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
